The DOI matches its Crossref record; 421 of the 427 references it cites were found in a registry or an index.
Cost of disorders of the brain in Europe 2010
Open accessAbstract
Background The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as well as short- and long-term impairments and disabilities. Therefore they are an emotional, financial and social burden to the patients, their families and their social network. In a 2005 landmark study, we estimated for the first time the annual cost of 12 major groups of disorders of the brain in Europe and gave a conservative estimate of €386 billion for the year 2004. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. We are now in a position to substantially improve and revise the 2004 estimates. In the present report we cover 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items. We therefore present much improved cost estimates. Our revised estimates also now include the new EU member states, and hence a population of 514 million people.Aims To estimate the number of persons with defined disorders of the brain in Europe in 2010, the total cost per person related to each disease in terms of direct and indirect costs, and an estimate of the total cost per disorder and country.Methods The best available estimates of the prevalence and cost per person for 19 groups of disorders of the brain (covering well over 100 specific disorders) were identified via a systematic review of the published literature. Together with the twelve disorders included in 2004, the following range of mental and neurologic groups of disorders is covered: addictive disorders, affective disorders, anxiety disorders, brain tumor, childhood and adolescent disorders (developmental disorders), dementia, eating disorders, epilepsy, mental retardation, migraine, multiple sclerosis, neuromuscular disorders, Parkinson's disease, personality disorders, psychotic disorders, sleep disorders, somatoform disorders, stroke, and traumatic brain injury. Epidemiologic panels were charged to complete the literature review for each disorder in order to estimate the 12-month prevalence, and health economic panels were charged to estimate best cost-estimates. A cost model was developed to combine the epidemiologic and economic data and estimate the total cost of each disorder in each of 30 European countries (EU27+Iceland, Norway and Switzerland). The cost model was populated with national statistics from Eurostat to adjust all costs to 2010 values, converting all local currencies to Euro, imputing costs for countries where no data were available, and aggregating country estimates to purchasing power parity adjusted estimates for the total cost of disorders of the brain in Europe 2010.Results The total cost of disorders of the brain was estimated at €798 billion in 2010. Direct costs constitute the majority of costs (37% direct healthcare costs and 23% direct non-medical costs) whereas the remaining 40% were indirect costs associated with patients' production losses. On average, the estimated cost per person with a disorder of the brain in Europe ranged between €285 for headache and €30,000 for neuromuscular disorders. The European per capita cost of disorders of the brain was €1550 on average but varied by country. The cost (in billion €PPP 2010) of the disorders of the brain included in this study was as follows: addiction: €65.7; anxiety disorders: €74.4; brain tumor: €5.2; child/adolescent disorders: €21.3; dementia: €105.2; eating disorders: €0.8; epilepsy: €13.8; headache: €43.5; mental retardation: €43.3; mood disorders: €113.4; multiple sclerosis: €14.6; neuromuscular disorders: €7.7; Parkinson's disease: €13.9; personality disorders: €27.3; psychotic disorders: €93.9; sleep disorders: €35.4; somatoform disorder: €21.2; stroke: €64.1; traumatic brain injury: €33.0. It should be noted that the revised estimate of those disorders included in the previous 2004 report constituted €477 billion, by and large confirming our previous study results after considering the inflation and population increase since 2004. Further, our results were consistent with administrative data on the health care expenditure in Europe, and comparable to previous studies on the cost of specific disorders in Europe. Our estimates were lower than comparable estimates from the US.Discussion This study was based on the best currently available data in Europe and our model enabled extrapolation to countries where no data could be found. Still, the scarcity of data is an important source of uncertainty in our estimates and may imply over- or underestimations in some disorders and countries. Even though this review included many disorders, diagnoses, age groups and cost items that were omitted in 2004, there are still remaining disorders that could not be included due to limitations in the available data. We therefore consider our estimate of the total cost of the disorders of the brain in Europe to be conservative. In terms of the health economic burden outlined in this report, disorders of the brain likely constitute the number one economic challenge for European health care, now and in the future. Data presented in this report should be considered by all stakeholder groups, including policy makers, industry and patient advocacy groups, to reconsider the current science, research and public health agenda and define a coordinated plan of action of various levels to address the associated challenges.Recommendations Political action is required in light of the present high cost of disorders of the brain. Funding of brain research must be increased; care for patients with brain disorders as well as teaching at medical schools and other health related educations must be quantitatively and qualitatively improved, including psychological treatments. The current move of the pharmaceutical industry away from brain related indications must be halted and reversed. Continued research into the cost of the many disorders not included in the present study is warranted. It is essential that not only the EU but also the national governments forcefully support these initiatives.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The economic costs of headaches are substantial, primarily manifesting as indirect and intangible costs. This includes work absences because of headaches (absenteeism), reduced on-the-job performance while experiencing headaches (presenteeism), reduced quality of life, and increased pain outside the workplace [5-7].”
In the citing paper
“Persistent depressive disorder (PDD) is characterized by psychosocial impairment (Angst et al. 2009; Gustavsson et al. 2011; Klein et al. 1988), high comorbidity (Köhler et al. 2019), low rates of spontaneous remission (McCullough et al. 1988) and poorer treatment outcomes compared to episodic depression (Stewart et al. 1989; Thase et al. 1994).”
From Reciprocal Dynamics of Therapeutic Alliance and Depressive Symptoms in Inpatient Cognitive Behavioural Analysis System of Psychotherapy: The Role of Attachment Insecurity. (2025) · cites this paper as Gustavsson et al. 2011
Citations
Cites
Items 201–400 of 421
Diagnoses Received by Narcolepsy Patients in the Year Prior to Diagnosis by a Sleep Specialist
Kryger, M. H., Walld, R., & Manfreda, J. (2002) · SLEEP · doi:10.1093/sleep/25.1.36 · Cited by 100
Schepelmann, K., Winter, Y., Spottke, A. E., Claus, D., Grothe, C., Schröder, R., Heuß, D. F., Vielhaber, S., Mylius, V., Kiefer, R., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5256-6 · Cited by 100
Self-citationSocial-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain
López‐Bastida, J., Serrano‐Aguilar, P., Perestelo‐Pérez, L., & Oliva, J. (2006) · Neurology · doi:10.1212/01.wnl.0000249311.80411.93 · Cited by 100
Healthcare costs of intellectual disability in the Netherlands: a cost‐of‐illness perspective
Polder, J. J., Meerding, W. J., Bonneux, L. G. A., & van der Maas, P. J. (2002) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.2002.00384.x · Cited by 98
Gustavsson, A., Jönsson, L., Rapp, T., Reynish, E. L., Ousset, P., Andrieu, S., Cantet, C., Winblad, B. G., Vellas, B. J., & Wimo, A. B. (2010) · The journal of nutrition health & aging · doi:10.1007/s12603-010-0311-7 · Cited by 98
Self-citationSillanpää, M. L. (1973) · PubMed · Cited by 97
Jönsson, L., Lindgren, P., Wimo, A. B., Jönsson, B., & Winblad, B. G. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80025-9 · Cited by 96
Self-citationNutt, D., & Goodwin, G. M. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.05.004 · Cited by 94
Costs and Offset Effect in Panic Disorders
Salvador‐Carulla, L., Seguı́, J., Fernández-Cano, P., & Canet, J. (1995) · The British Journal of Psychiatry · doi:10.1192/s0007125000293367 · Cited by 93
Self-citationIncreasing prevalence of multiple sclerosis in Finland
Sumelahti, M., Tienari, P. J., Wikstrom, J., Palo, J., & Hakama, M. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.103003153.x · Cited by 93
Predicting the cost of Parkinson's disease
McCrone, P., Allcock, L. M., & Burn, D. J. (2007) · Movement Disorders · doi:10.1002/mds.21360 · Cited by 93
Economic Impact of Migraine and Other Episodic Headaches in France
Pradalier, A., Auray, J., Hasnaoui, A. E., Alzahouri, K., Dartigues, J., Duru, G., Henry, P., Lantéri‐Minet, M., Lucas, C., Chazot, G., et al. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422150-00003 · Cited by 92
Prevalence of very mild to severe dementia in Denmark
Andersen, K., Lolk, A., Nielsen, H., Andersen, J., Olsen, C., & Kragh-Ssrensen, P. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1997.tb00244.x · Cited by 91
Principles underlying selection of outcomes in Alzheimer disease research.
Fortinsky, R. H., Hazuda, H. P., Larson, E. B., Lindeman, D. A., Mullican, C. A., Tetzloff, I., & Wetle, T. (1997) · PubMed · Cited by 91
Prevalence of Childhood Epilepsy in Estonia
Beilmann, A., Napa, A., Sööt, A., Talvik, I., & Talvik, T. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00811.x · Cited by 90
Costs and quality of life of multiple sclerosis in the United Kingdom
Kobelt, G., Berg, J., Lindgren, P., Kerrigan, J., Russell, N., & Nixon, R. M. (2006) · The European Journal of Health Economics · doi:10.1007/s10198-006-0380-z · Cited by 90
Self-citationThe Economic Consequences of Narcolepsy
Jennum, P., Knudsen, S., & Kjellberg, J. (2009) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27493 · Cited by 90
Self-citationPosttraumatic stress disorder: diagnostic and epidemiological perspectives.
Wïttchen, H., Gloster, A. T., Beesdo‐Baum, K., Schönfeld, S., & Perkonigg, A. (2009) · PubMed · Cited by 89
Whiteneck, G. G., Brooks, C., Mellick, D., Harrison-Felix, C. L., Sendroy-Terrill, M., & Noble, K. (2004) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2003.08.107 · Cited by 89
Brower, K. J., & Perron, B. E. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00035.x · Cited by 89
Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway
Smestad, C., Sandvik, L., Holmøy, T., Harbo, H. F., & Celius, E. G. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0659-8 · Cited by 87
Child Psychiatric Diagnoses in a Population of Dutch Schoolchildren Aged 6 to 8 Years
Kroes, M., Kalff, A. C., Kessels, A. G. H., Steyaert, J. G., FERON, F. J. M., van Someren, A., Hurks, P. P. M., Hendriksen, J. G. M., Zeben, T. M. C. B. V., Rozendaal, N., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200112000-00010 · Cited by 86
Prevalence of Dementia Subtypes in El Prat de Llobregat, Catalonia, Spain: The PRATICON Study
Gascón‐Bayarri, J., Reñé, R., del Barrio, J. L., de Pedro‐Cuesta, J., Ramón, J. M., Manubens, J. M., Sánchez, C., Hernández, M., Estela, J. L. C., Juncadella, M., et al. (2007) · Neuroepidemiology · doi:10.1159/000108597 · Cited by 84
Epidemiology of Myasthenia gravis: A Population-Based Study in Stockholm, Sweden
Kalb, B. T., Matell, G., Pirskanen, R., & Lambe, M. P. (2002) · Neuroepidemiology · doi:10.1159/000065639 · Cited by 83
Roijen, L. H., Hoeijenbos, M., Regeer, E. J., ten Have, M., Nolen, W. A., Veraart, C. P. W. M., & Rutten, F. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00403.x · Cited by 83
Krauth, C., Buser, K., & Vogel, H. (2002) · The European Journal of Health Economics · doi:10.1007/s10198-002-0137-2 · Cited by 81
The prevalence of dementia in 95 year olds
Börjesson‐Hanson, A., Edin, E., Gíslason, Þ., & Skoog, I. G. (2004) · Neurology · doi:10.1212/01.wnl.0000147260.52841.27 · Cited by 81
From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy
Tognoni, G., Ceravolo, R., Nucciarone, B., Bianchi, F., Dell’Agnello, G., Ghicopulos, I., Siciliano, G., & Murri, L. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00444.x · Cited by 80
Coduras, A., Rabasa, I., Frank, A., Bermejo‐Pareja, F., Pousa, S. L., López-Arrieta, J.-M., del Llano, J., León, T., & Rejas, J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1258 · Cited by 80
Jarl, J., Johansson, P., Eriksson, A., Eriksson, M., Gerdtham, U., Hemström, Ö., Selin, K. H., Lenke, L., Ramstedt, M., & Room, R. (2007) · The European Journal of Health Economics · doi:10.1007/s10198-007-0082-1 · Cited by 79
The Social Cost of Alcohol, Tobacco and Illicit Drugs in France, 1997
Fenoglio, P., Parel, V., & Kopp, P. (2003) · European Addiction Research · doi:10.1159/000067730 · Cited by 78
The number of persons with alcohol problems in the Danish population
Hansen, A. B. G., Hvidtfeldt, U. A., Grønbæk, M., Becker, U., Nielsen, A. S., & Tolstrup, J. S. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810393556 · Cited by 78
Broman, J., Mallon, L., & Hetta, J. E. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01825.x · Cited by 76
Hong, J., Windmeijer, F. A. G., Novick, D., Haro, J. M., & Brown, J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.034 · Cited by 76
Epidemiology of obstructive sleep apnea syndrome
Partinen, M. (1995) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-199511000-00009 · Cited by 75
de Zélicourt, M., Buteau, L., Fagnani, F., & Jallon, P. (2000) · Seizure · doi:10.1053/seiz.1999.0364 · Cited by 74
The burden of alcohol-related ill health in the United Kingdom
Balakrishnan, R., Allender, S. E., Scarborough, P., Webster, P., & Rayner, M. (2009) · Journal of Public Health · doi:10.1093/pubmed/fdp051 · Cited by 74
The costs of epilepsy in Italy
Tetto, A., Manzoni, P., Millul, A., Beghi, E., Garattini, L., Tartara, A., & AVANZINI, G. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00013-x · Cited by 73
Self-citationBeghi, E., Garattini, L., Ricci, E. D., Cornago, D., Parazzini, F., & EPICOS Group (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.14103.x · Cited by 73
Self-citationThe Epidemiology of childhood hyperactivity
Taylor, E. A. (1991) · Medical Entomology and Zoology · Cited by 72
Effects of insomnia and sleep medication on health-related quality of life
Sasai, T., Inoue, Y., Komada, Y., Nomura, T., Matsuura, M., & Matsushima, E. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2009.09.011 · Cited by 72
Costs and quality of life of multiple sclerosis in Sweden
Berg, J., Lindgren, P., Fredrikson, S., & Kobelt, G. (2006) · The European Journal of Health Economics · doi:10.1007/s10198-006-0379-5 · Cited by 72
Self-citationCosts and quality of life of multiple sclerosis in Germany
Kobelt, G., Berg, J., Lindgren, P., Elias, W. G., Flachenecker, P., Freidel, M., König, N., Limmroth, V., & Straube, E. (2006) · The European Journal of Health Economics · doi:10.1007/s10198-006-0384-8 · Cited by 72
Self-citationEstimating the Costs of Epilepsy: An International Comparison of Epilepsy Cost Studies
Kotsopoulos, I. A. W., Evers, S., Ament, A. J. H. A., & de Krom, M. C. T. F. M. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.18200.x · Cited by 71
Adelöw, C., Åndell, E., Åmark, P. E., Andersson, T., Hellebro, E., Ahlbom, A., & Tomson, T. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01726.x · Cited by 70
Door-to-Door Prevalence Survey of Epilepsy in Three Sicilian Municipalities
Rocca, W. A., Savettieri, G., Anderson, D. W., Meneghini, F., Grigoletto, F., Morgante, F., Reggio, A., Salemi, G., Patti, F., & Perri, R. D. (2001) · Neuroepidemiology · doi:10.1159/000054796 · Cited by 70
Grabe, H. J., Baumeister, S. E., John, U., Freyberger, H. J., & Völzke, H. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0005-9 · Cited by 69
Cost of Parkinson's disease in Europe
Lindgren, P., von Campenhausen, S., Spottke, E., Siebert, U., & Dodel, R. C. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01197.x · Cited by 69
Self-citationHigh utilizers of medical care
Hiller, W., & Fichter, M. M. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00628-7 · Cited by 69
Sleep duration and sleep-related problems in different occupations in the Hordaland Health Study
Ursin, R., Baste, V., & Moen, B. E. (2009) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.1325 · Cited by 68
The European Schizophrenia Cohort
Bebbington, P., Angermeyer, M. C., Azorin, J., Brugha, T. S., Kilian, R., Johnson, S., Toumi, M., & Kornfeld, A. (2005) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-005-0955-5 · Cited by 67
Costs of depression in Catalonia (Spain)
Salvador‐Carulla, L., Bendeck, M., Fernández, A., Albertí, C., Sabés-Figuera, R., Molina, C., & Knapp, M. R. J. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.02.019 · Cited by 66
Self-citationSivertsen, B., Nordhus, I. H., Bjorvatn, B., & Pallesen, S. (2009) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2009.00769.x · Cited by 66
Self-Assessed Cognitive Function in Snorers and Sleep Apneics
Jennum, P., & Sjøl, A. (2008) · European Neurology · doi:10.1159/000117039 · Cited by 65
Self-citationOlivares, J. M., Rodríguez-Martínez, A., Burón, J. A., Alonso‐Escolano, D., & Rodríguez-Morales, A. (2008) · Applied Health Economics and Health Policy · doi:10.2165/00148365-200806010-00004 · Cited by 64
Prevalence of mental disorders among children in Valencia, Spain
Gómez-Beneyto, M., Bonet, A. R., Catalá, M. A., Puche, E., & Vila, V. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01528.x · Cited by 64
Costs of Parkinson's disease in Eastern Europe: A Czech cohort study
Winter, Y., von Campenhausen, S., Brožová, H., Skoupá, J., Reese, J. P., Bötzel, K., Eggert, K. M., Oertel, W. H., Dodel, R. C., & Růžička, E. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.07.005 · Cited by 64
Self-citationCost of affective disorders in Europe
Andlin‐Sobocki, P., & Wïttchen, H. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01195.x · Cited by 64
Livingston, G., Katona, C., Roch, B., Guilhaume, C., & Rive, B. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003980 · Cited by 64
Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy
Mahdi‐Rogers, M., Kazmi, M. A., Ferner, R. E., Hughes, R. A., Renaud, S., Steck, A. J., Fuhr, P., Halter, J. P., Gratwohl, A. A., & Tyndall, A. (2009) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2009.00221.x · Cited by 64
Direct and Indirect Costs Attributable to Alcohol Consumption in Germany
Konnopka, A., & nig, H.-H. K. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725070-00006 · Cited by 64
Future costs of stroke in the Netherlands: The impact of stroke services
Struijs, J. N., van Genugten, M. L. L., Evers, S., Ament, A. J. H. A., Baan, C. A., & van den Bos, G. A. M. (2006) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462306051464 · Cited by 64
Costs and quality of life of multiple sclerosis in Italy
Kobelt, G., Berg, J., Lindgren, P., Battaglia, M. A., Lucioni, C., & Uccelli, A. (2006) · The European Journal of Health Economics · doi:10.1007/s10198-006-0385-7 · Cited by 64
Self-citationBerg, J., Tagliaferri, F., & Servadei, F. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01200.x · Cited by 63
Adamis, D., & Ball, C. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(200003)15:3 · Cited by 63
The Cost of Dementia in Denmark: The Odense Study
Andersen, C. K., Søgaard, J., Hansen, E., Kragh-Sørensen, A., Hastrup, L. H., Andersen, J., Andersen, K., Lolk, A., Nielsen, H., & Kragh-Sørensen, P. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017135 · Cited by 63
An Economic Perspective on Alzheimer's Disease
Trabucchi, M. (1999) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901200107 · Cited by 63
Young, T. B. (1996) · SLEEP · doi:10.1093/sleep/19.7.529 · Cited by 63
Cost of treatment of schizophrenia in six European countries
Salize, H. J., McCabe, R., Bullenkamp, J., Hansson, L. I., Lauber, C., Martínez‐Leal, R., Reinhard, I., Wulf Rössler, A., Svensson, B., Torres‐González, F., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.027 · Cited by 62
Prevalence of Epilepsy in Northeast Madrid
Parra, J., Col�s, J., R�mos, F., Carreras, T., Fern�ndez-Pozos, M. J., Luengo, A., Mu�oz, A., & Hernando, V. (2001) · Journal of Neurology · doi:10.1007/s004150170091 · Cited by 61
Martínez‐Leal, R., Salvador‐Carulla, L., Linehan, C., Walsh, P. N., Weber, G., Hove, G. V., Määttä, T., Azéma, B., Haveman, M. J., Buono, S., et al. (2011) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2011.01439.x · Cited by 61
Self-citationThe direct costs of insomnia in France.
Léger, D., Lévy, É., & Paillard, M. (1999) · PubMed · Cited by 61
The Eurolight project: the impact of primary headache disorders in Europe. Description of methods
Andrée, C., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., Lainez, J. M., Lanteri-Minet, M., Mick, G., Rastenyte, D., de la Torre, E. R., et al. (2011) · The Journal of Headache and Pain · doi:10.1007/s10194-011-0356-y · Cited by 60
Self-citationEconomic Analysis of Alzheimer’s Disease in Outpatients: Impact of Symptom Severity
Souêtre, E., Qing, W., Vigoureux, I., Dartigues, J., Lozet, H., Lacomblez, L., & Derouesné, C. (1995) · International Psychogeriatrics · doi:10.1017/s1041610295001906 · Cited by 60
Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey
Ranzato, F., de Perini, P., Tzintzeva, E., Tiberio, M., Calabrese, M., Ermani, M., Davetag, F., Zanche, L. D., Garbin, E., Verdelli, F., et al. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms920oa · Cited by 60
Packer, R. J., MacDonald, T. J., & Vézina, G. (2008) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2007.10.010 · Cited by 60
Hetta, J., Broman, J.-E., & Mallon, L. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901304s10 · Cited by 59
The costs of schizophrenia in Spain
Oliva, J., López‐Bastida, J., Osuna-Guerrero, R., Montejo, A. L., & Duque-González, B. (2006) · The European Journal of Health Economics · doi:10.1007/s10198-006-0350-5 · Cited by 59
Gerzeli, S., Tarricone, R., Zolo, P., Colangelo, I., Busca, M. R., & Gandolfo, C. (2005) · Neurological Sciences · doi:10.1007/s10072-005-0439-0 · Cited by 59
Forsgren, I., Beghi, E., & Ekman, M. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01191.x · Cited by 59
Self-citationHausken, A. M., Furu, K., Skurtveit, S. O., Engeland, A., & Bramness, J. G. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0565-8 · Cited by 59
Prevalence of adult epilepsy in Estonia
Õun, A., Haldre, S., & Mägi, M. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(02)00234-6 · Cited by 58
Wïttchen, H., Beesdo‐Baum, K., Gloster, A. T., Höfler, M., Klotsche, J., Lieb, R., Beauducel, A., Bühner, M., & Kessler, R. C. (2009) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.298 · Cited by 58
Self-citationPatients with Alzheimer's Disease Living at Home in France: Costs and Consequences of the Disease
Rigaud, A., Bayle, C., Fagnani, F., Latour, F., Traykov, L. D., & Forette, F. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988703252558 · Cited by 57
Giuliani, G., Terziani, S., Senigaglia, A. R., Luccioni, G., Foschi, N., & Maffei, C. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb03991.x · Cited by 57
Incidence of epilepsy and predictive factors of epileptic and non-epileptic seizures
Kotsopoulos, I. A. W., de Krom, M. C. T. F. M., Kessels, F., Lodder, J., Troost, J., Twellaar, M., Merode, T. V., & Knottnerus, J. A. (2005) · Seizure · doi:10.1016/j.seizure.2005.01.005 · Cited by 57
Cost-of-Illness of Epilepsy in Italy
Berto, P., Tinuper, P., & Viaggi, S. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017020-00008 · Cited by 56
Costs and quality of life for patients with multiple sclerosis in Belgium
Kobelt, G. (2006) · The European Journal of Health Economics · doi:10.1007/s10198-006-0377-7 · Cited by 56
Self-citationPrevalence of multiple sclerosis
Poser, C. M. (1992) · Annals of Neurology · doi:10.1002/ana.410320520 · Cited by 56
Economic burden of drug dependency
Healey, A., Knapp, M. R. J., Astin, J., Gossop, M., Marsden, J., Stewart, D., Lehmann, P., & Godfrey, C. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.173.2.160 · Cited by 56
Self-citationInsomnia Symptoms and Use of Health Care Services and Medications: The HUNT-2 Study
Sivertsen, B., Krokstad, S., Mykletun, A., & Øverland, S. N. (2009) · Behavioral Sleep Medicine · doi:10.1080/15402000903190199 · Cited by 55
Examining the prevalence of epilepsy and delivery of epilepsy care in Ireland
Linehan, C., Kerr, M. P., Walsh, P. N., Brady, G., Kelleher, C., Delanty, N., Dawson, F., & Glynn, M. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02417.x · Cited by 54
Chasens, E. R., Twerski, S. R., Yang, K., & Umlauf, M. G. (2010) · Behavioral Sleep Medicine · doi:10.1080/15402002.2010.487462 · Cited by 54
Andlin‐Sobocki, P., & Rehm, J. T. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01194.x · Cited by 54
Self-citationVariable costs of ICU patients: a multicenter prospective study
Rossi, C., Simini, B., Brazzi, L., Rossi, G., Radrizzani, D., Iapichino, G., & Bertolini, G. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0080-2 · Cited by 54
Die direkten Kosten von depressiven Erkrankungen in Deutschland
Friemel, S., Bernert, S., Angermeyer, M. C., & König, H. (2005) · Psychiatrische Praxis · doi:10.1055/s-2004-834611 · Cited by 54
The Maudsley long-term follow-up of child and adolescent depression
McCrone, P., Knapp, M. R. J., & Fombonne, E. J. (2005) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-005-0491-6 · Cited by 53
Self-citationMultiple sclerosis in the province of Ferrara
Granieri, E., Economou, N.-T., Gennaro, R., Tola, M. R., Caniatti, L. M., Govoni, V., Fainardi, E., & Casetta, I. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0560-5 · Cited by 53
Boada, M., Peña‐Casanova, J., Bermejo, F., Guillén, F., Hart, W. M., Espinosa, C., & Rovira, J. (1999) · PubMed · Cited by 53
Benedikz, J. E. G., Stefánsson, M., Guðmundsson, J., Jónasdóttir, A., Fossdal, R., Gulcher, J., & Stefánsson, K. (2002) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(02)00040-9 · Cited by 53
Jönsson, L., & Berr, C. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01190.x · Cited by 52
Self-citationCosts and quality of life in multiple sclerosis in The Netherlands
Kobelt, G., Berg, J., & Lindgren, P. (2006) · The European Journal of Health Economics · doi:10.1007/s10198-006-0378-6 · Cited by 52
Self-citationPrevalence of narcolepsy with cataplexy in Norway
Heier, M., Evsiukova, T., Wilson, J. A., Abdelnoor, M., Hublin, C., & Ervik, S. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01166.x · Cited by 52
A cohort study of the prevalence of sleep problems in adults with intellectual disabilities
BOYLE, A., Melville, C. A., Morrison, J., Allan, L., Smiley, E., Espie, C. A., & Cooper, S. (2009) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2009.00788.x · Cited by 51
Resource allocation to brain research in Europe (RABRE)
Sobocki, P., Lekander, I., Berwick, S., Olesen, J., & Jönsson, B. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05116.x · Cited by 51
Self-citationCost of psychotic disorders in Europe
Andlin‐Sobocki, P., & Wulf Rössler, A. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01198.x · Cited by 50
Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland
Gray, O., McDonnell, G. V., & Hawkins, S. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508090663 · Cited by 50
Relationship between smoking and sleep apnea in clinic population.
Hoflstein (2002) · PubMed · Cited by 50
Cost Effectiveness of Memantine in???Moderately Severe to Severe Alzheimer???s Disease
Fran??ois, C., Sintonen, H., Sulkava, R. O., & Rive, B. (2004) · Clinical Drug Investigation · doi:10.2165/00044011-200424070-00001 · Cited by 49
Li, X., Sundquist, K., & Sundquist, J. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.02.003 · Cited by 49
Incidence of Epilepsies and Epileptic Syndromes Among Children in Navarre, Spain: 2002 Through 2005
Durá-Travé, T., Yoldi-Petri, M. E., & Gallinas-Victoriano, F. (2008) · Journal of Child Neurology · doi:10.1177/0883073808314898 · Cited by 48
The Costs of Childhood Epilepsy in Italy: Comparative Findings from Three Health Care Settings
Guerrini, R., Battini, R., Ferrari, A. R., Veggiotti, P., Besana, D., Gobbi, G., Pezzani, M., Berta, E., Tetto, A., Beghi, E., et al. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.27300.x · Cited by 48
Self-citationKobelt, G., Texier-Richard, B., & Lindgren, P. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509102771 · Cited by 48
Self-citationCasado, V., Martínez‐Yélamos, S., Martı́nez-Yélamos, A., Carmona, O., Alonso, L., Romero-Pinel, L., Moral, E., Gubieras, L., & Arbizu, T. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-143 · Cited by 48
Prevalence and Incidence of Multiple Sclerosis in Western Greece: A 23-Year Survey
Papathanasopoulos, P., Gourzoulidou, E., Messinis, L., Georgiou, V., & Leotsinidis, M. (2008) · Neuroepidemiology · doi:10.1159/000122334 · Cited by 47
A prospective study of the financial costs of multiple sclerosis at different stages of the disease
Orlewska, E., Mierzejewski, P., Zaborski, J., Kruszewska, J., Wicha, W., Fryze, W., Drozdowski, W., Skibicka, I., Mirowska-Guzel, D. M., Członkowski, A., et al. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00950.x · Cited by 47
A population based epidemiological study on myasthenia gravis in Estonia
Ööpik, M. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.12.1638 · Cited by 47
Wellis, G. N., Nagel, R., Vollmar, C., & Steiger, H. (2003) · Acta Neurochirurgica · doi:10.1007/s00701-003-0007-4 · Cited by 46
Health service use by adults with depression: community survey in five European countries
McCracken, C., Dalgard, O. S., Ayuso‐Mateos, J. L., Casey, P., Wilkinson, G., Lehtinen, V., & Dowrick, C. F. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.105.015081 · Cited by 46
Snoring and Nocturnal Oxygen Desaturations in an Italian Middle-aged Male Population
Ferini‐Strambi, L., Zucconi, M., Palazzi, S., Castronovo, V., Oldani, A., Marca, G. D., & Smirne, S. (1994) · CHEST Journal · doi:10.1378/chest.105.6.1759 · Cited by 45
Descriptive Epidemiologic Study of Epilepsy Syndromes in a District of Northwest Tuscany, Italy
Maremmani, C., Rossi, G., Bonuccelli, U., & Murri, L. (1991) · Epilepsia · doi:10.1111/j.1528-1157.1991.tb04654.x · Cited by 45
The impact of somatic health problems on insomnia in middle age
Martikainen, K. K., Partinen, M., Hasan, J., Laippala, P., Urponen, H., & VUORI, I. M. (2002) · Sleep Medicine · doi:10.1016/s1389-9457(02)00194-6 · Cited by 44
The prevalence of clinically significant sleep apnoea syndrome in the Netherlands
Neven, A. K., Middelkoop, H. A. M., Kemp, B., KAMPHUISEN, H. A. C., & Springer, M. P. (1998) · Thorax · doi:10.1136/thx.53.8.638 · Cited by 44
The economic impact of dementia in Belgium: results of the National Dementia Economic Study (NADES).
Scuvee-Moreau, J., Kurz, X., & DRESSE, A. E. (2002) · PubMed · Cited by 44
Prevalence of sleep apnea in healthy industrial workers
Peter, J. H., Siegrist, J., Podszus, T., Mayer, J., Selzer, K., & Wichert, P. V. (1985) · Journal of Molecular Medicine · doi:10.1007/bf01732285 · Cited by 43
Costs and quality of life of multiple sclerosis in Switzerland
Kobelt, G., Berg, J., Lindgren, P., Gerfin, A., & Lütz, J. (2006) · The European Journal of Health Economics · doi:10.1007/s10198-006-0383-9 · Cited by 43
Self-citationRelationship Between Smoking and Sleep Apnea in Clinic Population
Hoffstein, V. (2002) · SLEEP · doi:10.1093/sleep/25.5.517 · Cited by 43
Brain tumours in Sweden 1996: care and costs
Blomqvist, P. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.6.792 · Cited by 43
The economic cost of schizophrenia in Ireland: a cost of illness study
Behan, C. L., Kennelly, B., & O’Callaghan, E. (2008) · Irish Journal of Psychological Medicine · doi:10.1017/s079096670001106x · Cited by 43
Sancho, J., Peña, P., Rufo, M., Palacios, G., Masramon, X., & Rejas, J. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.05.008 · Cited by 42
Prevalence of multiple sclerosis in Santiago de Compostela (Galicia, Spain)
Ares, B., Prieto, J. M., Lema, I., Dapena, D., Arias, M., & Noya, M. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506069540 · Cited by 42
Salize, H. J., Stamm, K., Schubert, M., Bergmann, F., Härter, M. C., Berger, M., Gäebel, W., & Schneider, F. W. (2004) · Psychiatrische Praxis · doi:10.1055/s-2003-814828 · Cited by 42
Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barré syndrome
Espérou, H., Jars-Guincestre, M. C., Bolgert, F., Raphaël, J.-C., & Durand‐Zaleski, I. (2000) · Intensive Care Medicine · doi:10.1007/s001340051323 · Cited by 41
Psychosocial Correlates of Insomnia Severity in Primary Care
Bluestein, D. A., Rutledge, C., & Healey, A. C. (2010) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2010.02.090179 · Cited by 41
Epilepsy in mainstream and special educational primary school settings
TIDMAN, L., SARAVANAN, K., & GIBBS, J. (2002) · Seizure · doi:10.1016/s1059131102001711 · Cited by 40
In-patient care costs of patients with bipolar I disorder: A comparison between two European centers
González-Pinto, A. M., Dardennes, R. M., de Zélicourt, M., López, P., Oliveros, R. G., Vieta, E., Barbeito, S., Echevarría, E. M., & Fagnani, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.05.010 · Cited by 40
The costs of epilepsy in three different populations of patients with epilepsy
Kotsopoulos, I. A. W., Evers, S., Ament, A. J. H. A., Kessels, F., de Krom, M. C. T. F. M., Twellaar, M., Metsemakers, J. F. M., & Knottnerus, J. A. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(03)00062-7 · Cited by 40
Study of the Prevalence of Epilepsy Among Schoolchildren in Valladolid, Spain
Sangrador, C. O., & Luaces, R. P. (1991) · Epilepsia · doi:10.1111/j.1528-1157.1991.tb05535.x · Cited by 40
Prevalence of childhood epilepsy in Kaunas, Lithuania
Endzinienė, M., Pauza, V., & Misevičienė, I. (1997) · Brain and Development · doi:10.1016/s0387-7604(97)00035-1 · Cited by 39
Prevalence of Multiple Sclerosis in Austria
Baumhackl, U., Eibl, G., Ganzinger, U., Hartung, H., Mamoli, B., Pfeiffer, K. P., Fazekas, F., & Vass, K. (2002) · Neuroepidemiology · doi:10.1159/000065640 · Cited by 39
The social cost of illegal drug consumption in Spain
García‐Altés, A., Ollé, J. M., Antoñanzas, F., & Colom, J. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00170.x · Cited by 38
Psychiatric disturbances among prepubertal children in Southern Finland
Puura, K., Almqvist, F., Tamminen, T., Piha, J., Räsänen, E., Kumpulainen, K., Moilanen, I., & Koivisto, A. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050060 · Cited by 38
Roy, A. N., & Smith, M. J. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2009.09.012 · Cited by 38
Frequency of Hospitalisations and Inpatient Care Costs of Manic Episodes
de Zélicourt, M., Dardennes, R. M., Verdoux, H., Gandhi, G., Khoshnood, B., Chomette, E., Papatheodorou, M.-L., Edgell, E. T., EVEN, C., & Fagnani, F. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321150-00002 · Cited by 37
Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death
Wasserfallen, J.-B., Ostermann, S., Leyvraz, S., & Stupp, R. (2005) · Neuro-Oncology · doi:10.1215/s1152851704000687 · Cited by 37
Prevalence and Characteristics of Epilepsy in the Aeolian Islands
Gallitto, G., Serra, S., Spina, P. L., Postorino, P., Laganà, A., Tripodi, F., Gangemi, S., Calabrò, S., Savica, R., Perri, R. D., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00278.x · Cited by 37
Self-citationOutcome in 1,000 Head Injury Hospital Admissions: The Athens Head Trauma Registry
Stranjalis, G., Bouras, T. I., Korfias, S. I., Andrianakis, I. A., Pitaridis, M. T., Tsamandouraki, K., Alamanos, Y., Sakas, D. E., & Marmarou, A. (2008) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181469e26 · Cited by 36
Costs of Parkinson’s Disease and Antiparkinsonian Pharmacotherapy: An Italian Cohort Study
Winter, Y., von Campenhausen, S., Reese, J. P., Balzer‐Geldsetzer, M., Longo, K., Spiga, G., Boetzel, K., Eggert, K. M., Oertel, W. H., Dodel, R. C., et al. (2010) · Neurodegenerative Diseases · doi:10.1159/000302644 · Cited by 36
Self-citationPrevalence of epilepsy in Croatia: a population-based survey
Bielen, I., Cvitanović-Šojat, L., Bergman-Marković, B., Košiček, M., Planjar-Prvan, M., Vuksic, L., Miketek, G., Matek, P., & the ‘Collaborative Group for Study of Epilepsy Epidemiology in Croatia’ (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00881.x · Cited by 36
The cost of epilepsy in patients attending a specialist epilepsy service
Swingler, R. J., Davidson, D. L. W., ROBERTS, R. C., & Moulding, F. (1994) · Seizure · doi:10.1016/s1059-1311(05)80201-8 · Cited by 36
Multiple sclerosis in Malta in 1999: an update
Dean, G. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.3.256 · Cited by 35
The prevalence of multiple sclerosis in the north?west Italian province of Genoa
Solaro, C. M., Allemani, C., Uccelli, M. M., Canevari, E., Dagnino, N., Pizio, R., Regesta, G., Tanganelli, P., Battaglia, M. A., & Mancardi, G. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0670-x · Cited by 34
The prevalence of multiple sclerosis in the District of Santarém, Portugal
Sá, J., Paulos, A. R. T., Mendes, H., Becho, J., Marques, J., & Roxo, J. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0132-0 · Cited by 34
High prevalence of multiple sclerosis in the Swedish county of Värmland
Boström, I., Callander, M., Kurtzke, J. F., & Landtblom, A. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509345909 · Cited by 34
Determinants of hospital costs associated with traumatic brain injury in England and Wales*
Stephen Morris, A., Ridley, S., Lecky, F. E., Munro, V., & Christensen, M. C. (2008) · Anaesthesia · doi:10.1111/j.1365-2044.2007.05432.x · Cited by 33
Psychiatric admissions and hospitalization costs in bipolar disorder in Sweden
Ösby, U., Tiainen, A., Backlund, L., Edman, G., Adler, M., Hällgren, J., Sennfält, K., van Baardewijk, M., & Sparén, P. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.09.011 · Cited by 33
Prevalence and incidence of Alzheimers disease and other dementing disorders in Pylea, Greece
Tsolaki, M., Fountoulakis, C., Pavlopoulos, I., Chatzi, E., & Kazis, A. (1999) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331759901400308 · Cited by 33
Heider, D., Bernert, S., König, H., Matschinger, H., Hogh, T., Brugha, T. S., Bebbington, P., Azorin, J. M., Angermeyer, M. C., & Toumi, M. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2008.12.013 · Cited by 33
Stiller, C. A., & Bunch, K. J. (1992) · Europe PMC (PubMed Central) · Cited by 33
Mahler, M.-P., Züger, K., Kaspar, K., Haefeli, A., Jenni, W., Leniger, T., & Beer, J. H. (2008) · Swiss Medical Weekly · doi:10.4414/smw.2008.11845 · Cited by 32
Latvala, A., Tuulio‐Henriksson, A., Perälä, J., Saarni, S. I., Aalto‐Setälä, T., Aro, H. M., Korhonen, T., Koskinen, S. V. P., Lönnqvist, J. K., Kaprio, J. A., et al. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-73 · Cited by 31
Manic episodes: the direct cost of a three-month period following hospitalisation
Olié, J. P., & Lévy, É. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)00680-6 · Cited by 31
Health Economics of Chronic Obstructive Pulmonary Disease
Halpin, D. M. G. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200507-072sf · Cited by 31
Costs and quality of life of multiple sclerosis in Austria
Kobelt, G., Berg, J., Lindgren, P., Plesnila-Frank, C., Baumhackl, U., Berger, T., Kollegger, H., & Vass, K. (2006) · The European Journal of Health Economics · doi:10.1007/s10198-006-0382-x · Cited by 31
Self-citationRegion with persistent high frequency of multiple sclerosis in Croatia and Slovenia
Peterlin, B., Ristiæ, S., Sepèiæ, J., Končan-Vračko, B., Rako, A., Lovrečić, L., Brajenović‐Milić, B., Rude, J., Materljan, E., & Kapoviæ, M. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.04.002 · Cited by 30
Partinen, M., Hublin, C., Kaprio, J. A., Koskenvuo, M., & Guilleminault, C. (1994) · SLEEP · doi:10.1093/sleep/17.suppl_8.s13 · Cited by 29
The prealence of multiple sclerosis in the Hungarian city of Szeged
Bencsik, K., Rajda, C., Kliényi, P., Járdánházy, T., & Vécsei, L. (1998) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb05959.x · Cited by 29
Priebe, S., Gavrilovic, J., Matanov, A., Frančišković, T., Knežević, G., Ljubotina, D., Mehmedbasić, A. B., & Schützwohl, M. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.6.598 · Cited by 29
The costs of managing patients with malignant glioma at a neuro-oncology clinic*
Latif, A. Z. B., Signorini, D., Gregor, A., & Whittle, I. R. (1998) · British Journal of Neurosurgery · doi:10.1080/02688699845230 · Cited by 29
Krankheitskosten der Parkinson-Erkrankung
Dodel, R. C., Singer, M., Köhne-Volland, R., Selzer, R., Scholz, W., Rathay, B., & Oertel, W. H. (1997) · Der Nervenarzt · doi:10.1007/s001150050226 · Cited by 28
Self-citationAntiepileptic Drugs as 'Tracers' of Disease
Beghi, E., Monticelli, M. L., Monza, G. C., Sessa, A., & Zarrelli, M. M. (1991) · Neuroepidemiology · doi:10.1159/000110245 · Cited by 28
Self-citationPrevalence and incidence of multiple sclerosis in Salerno (southern Italy) and its province
Iuliano, G., & Napoletano, R. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.02006.x · Cited by 28
Age-specific prevalence of epilepsy in Oppland County, Norway
Svendsen, T., Lossius, M. I., & Nakken, K. O. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00909.x · Cited by 28
Epilepsy in the northern Finland birth cohort 1966 with special reference to fertility
Löfgren, E., Pouta, A. M., von Wendt, L., Tapanainen, J. S., Isojärvi, J. I. T., & Järvelin, M. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.08.007 · Cited by 27
Costs of schizophrenia during 5 years
Lindström, E., Eberhard, J., Neovius, M., & Levander, S. E. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01086.x · Cited by 27
Prevalence of Habitual Snoring in a Sample of French Males
Teculescu, D., Hannhart, B., Cornette, A., Montaut-Verient, B., Virion, J., & Michaely, J.-P. (2001) · Respiration · doi:10.1159/000050528 · Cited by 27
Russo, P., Capone, A., Paolillo, A., Macchia, F., Ranzato, F., Costantino, G., Esposti, L. D., & Caprino, L. (2004) · Clinical Drug Investigation · doi:10.2165/00044011-200424070-00004 · Cited by 26
Lauber, C., Keller, C., Eichenberger, A., & Wulf Rössler, A. (2005) · International Journal of Social Psychiatry · doi:10.1177/0020764005057376 · Cited by 26
Burden of disease related to Parkinson's disease in Spain in the year 2000
Cubo, E., Álvarez-Barco, E., Morant, C., Cuesta, J. D. P., Martín, P. M., Gènova, R., & Freire, J. M. (2005) · Movement Disorders · doi:10.1002/mds.20622 · Cited by 26
Sicras‐Mainar, A., Blanca-Tamayo, M., Gutiérrez-Nicuesa, L., Salvatella-Pasant, J., & Navarro‐Artieda, R. (2009) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2009.05.012 · Cited by 26
Schatzberg, S. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3949-5.50027-3 · Cited by 26
Incidence of Multiple Sclerosis in the Urban Area of Erfurt, Thuringia, Germany
Fasbender, P., & Kölmel, H. W. (2008) · Neuroepidemiology · doi:10.1159/000122331 · Cited by 23
The socio-economical burden of hypersomnia
Jennum, P., & Kjellberg, J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01227.x · Cited by 22
Self-citationGarattini, L., Barbui, C., Clemente, R., Cornago, D., Parazzini, F., & behalf of the Study Group SCORE (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007079 · Cited by 22
HLA and Hypocretin Studies in Korean Patients with Narcolepsy
Hong, S., Leen-Kim, Park, S.-A., Han, J., Lee, S.-P., Lin, L., Okun, M. L., Nishino, S., & Mignot, E. J.-M. (2002) · SLEEP · doi:10.1093/sleep/25.4.432 · Cited by 22
Snoring & Sleep Apnea: A Population Study in Italian Women
Ferini‐Strambi, L., Zucconi, M., Castronovo, V., Garancini, P., Oldani, A., & Smirne, S. (1999) · SLEEP · doi:10.1093/sleep/22.7.859 · Cited by 21
Morbus Parkinson: Krankheitskosten einer ambulanten Patientenkohorte
Reese, J., Winter, Y., Balzer‐Geldsetzer, M., Bötzel, K., Eggert, K. M., Oertel, W. H., Dodel, R. C., & von Campenhausen, S. (2010) · Das Gesundheitswesen · doi:10.1055/s-0030-1247571 · Cited by 21
Self-citationPattern of healthcare resource utilization and direct costs associated with manic episodes in Spain
Tafalla, M., Salvador‐Carulla, L., Sáiz-Ruiz, J., Díez, T., & Cordero, L. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-31 · Cited by 21
Self-citationCosting substance misuse services
Coyle, D., Godfrey, C., Hardman, G., & Raistrick, D. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02980.x · Cited by 20
Severity of Narcolepsy Among French of Different Ethnic Origins (South of France and Martinique)
Dauvilliers, Y. A., Bazin, M., Ondzé, B., Béra, O., Bazin, M., Besset, A., & Billiard, M. M. (2002) · SLEEP · doi:10.1093/sleep/25.1.50 · Cited by 20
The Incidence Rate of Seizures in Relation to BMI in UK Adults
Gao, S., Juhaeri, J., & Dai, W. S. (2008) · Obesity · doi:10.1038/oby.2008.310 · Cited by 19
Prospektive Erfassung der direkten und indirekten Kosten des idiopathischen Parkinson-Syndroms
Dengler, I., Leukel, N., Meuser, T., & Jost, W. H. (2006) · Der Nervenarzt · doi:10.1007/s00115-006-2150-7 · Cited by 19
Direkte Kosten der Parkinson-Behandlung
Ehret, R., Balzer‐Geldsetzer, M., Reese, J. P., Dodel, I., Becker, E., Christopher, A., Friedrich, H., Kraemer, S., Lüer, W., Müngersdorf, M., et al. (2009) · Der Nervenarzt · doi:10.1007/s00115-009-2671-y · Cited by 18
Self-citationKrankheitskosten und Versorgungssituation bei Morbus Parkinson – eine Analyse in Österreich
von Campenhausen, S., Winter, Y., Gasser, J., Seppi, K., Reese, J.-P., Pfeiffer, K. P., Geiger-Gritsch, S., Bötzel, K., Siebert, U., Oertel, W. H., et al. (2009) · Wiener klinische Wochenschrift · doi:10.1007/s00508-009-1223-6 · Cited by 16
Self-citationThe Social Costs of Alcohol Misuse in Estonia
Saar, I. (2008) · European Addiction Research · doi:10.1159/000173010 · Cited by 16
Epilepsy prevalence by individual interview in a Norwegian community
Brodtkorb, E., & Sjaastad, O. (2008) · Seizure · doi:10.1016/j.seizure.2008.03.005 · Cited by 16
[Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
Maurel, F., Lilliu, H., & Pen, C. L. (2001) · PubMed · Cited by 15
Hamre, H. J., Glockmann, A., Tröger, W., Kienle, G. S., & Kiene, H. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-11 · Cited by 14
Sicras‐Mainar, A., Blanca-Tamayo, M., Gutiérrez-Nicuesa, L., Salvatella-Pasant, J., & Navarro‐Artieda, R. (2010) · Hispana · Cited by 14
Analyse der direkten Kosten in der Parkinson-Therapie
Keller, S., Kessler, T., Meuser, T., Fogel, W., Bremen, D., & Jost, W. H. (2003) · Der Nervenarzt · doi:10.1007/s00115-003-1582-6 · Cited by 13
Flagged first, then by citations
6 of the 427 references couldn’t be matched to a known paper.
Research works printed but not linked: 8
- Atance Martinez, 2004, Costs study in Alzheimer's disease, Rev. Clin. Esp., 204, 64
- Bertelli, 2009, New contributions of psychiatric research in the field of intellectual disabilities, Adv. Psychiatry, 3, 37
- Cavallo, 1997, The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy, Alzheimer Dis. Assoc. Disord., 11, 184
- Gessner, 1993, The cost of epilepsy in Switzerland, Int. J. Health Sci., 4, 121
- Mahdi-Rogers, 2008, Epidemiology and treatment of chronic inflammatory neuropathies in South East England, Eur. J. Neurol., 15
- Salize, 2004, Cost of care for depressive disorders in primary and specialized care in Germany, Psychiatr. Prax., 31, 147
- Wilms, 2004, Illness related costs for spouses of patients suffering from a mental illness: results of a study with repeated measurements, Psychiatr. Prax., 31, 177
- Wittchen, 2010, The timing of depression: an epidemiological perspective, Medicographia, 32, 155-125
Cited by
Sorted by citations
eQTLGen, Wray, N. R., 23andMe, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A., Adams, M. J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0090-3 · Cited by 3,005
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research
Maas, A. I. R., Menon, D. K., Adelson, P. D., Andelic, N., Bell, M. J., Belli, A., Bragge, P., Brazinova, A., Büki, A., Chesnut, R. M., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30371-x · Cited by 2,609
Katan, M., & Luft, A. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1649503 · Cited by 2,137
European guideline for the diagnosis and treatment of insomnia
Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., Espie, C. A., Garcia‐Borreguero, D., Gjerstad, M., Gonçalves, M., et al. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12594 · Cited by 2,049
Self-citationDefeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Self-citation
Metadata
- Authors
- Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., Gannon, B., Jones, D. H., Jennum, P., Jordanova, A., Jönsson, L., Karampampa, K., Knapp, M., Kobelt, G., Kurth, T., Lieb, R., Linde, M., Ljungcrantz, C., Maercker, A., Melin, B., Moscarelli, M., Musayev, A., Norwood, F., Preisig, M., Pugliatti, M., Rehm, J., Salvador-Carulla, L., Schlehofer, B., Simon, R., Steinhausen, H.-C., Stovner, L. J., Vallat, J.-M., den Bergh, P. V., van Os, J., Vos, P., Xu, W., Wittchen, H.-U., Jönsson, B., & Olesen, J.
- Affiliations
- Karlstad University (SE)
- Technische Universität Dresden (DE)
- Karolinska University Hospital (SE)
- Municipal Institute for Medical Research (ES)
- Mario Negri Institute for Pharmacological Research (IT)
- Philipps University of Marburg (DE)
- University of Florence (IT)
- Karolinska Institutet (SE)
- University of Leeds (GB)
- Glostrup Hospital (DK)
- University of Antwerp (BE)
- King's College London (GB)
- Lund University (SE)
- Harvard University (US)
- University of Basel (CH)
- Norwegian University of Science and Technology (NO)
- Umeå University (SE)
- King's College Hospital (GB)
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Sassari (IT)
- German Cancer Research Center (DE)
- European Monitoring Centre for Drugs and Drug Addiction (PT)
- Aalborg University Hospital (DK)
- Centre Hospitalier Universitaire de Limoges (FR)
- Radboud University Nijmegen (NL)
- Stockholm School of Economics (SE)
- Corresponding author
- Olesen, Jes
- ORCID
- Gustavsson, Anders
- Svensson, Mikael
- Jacobi, Frank
- Alonso, Jordi
- Beghi, Ettore
- Dodel, Richard
- Ekman, Mattias
- Fratiglioni, Laura
- Gannon, Brenda
- Jennum, Poul
- Jordanova, Albena
- Jönsson, Linus
- Karampampa, Korinna
- Knapp, Martin
- Kobelt, Gisela
- Kurth, Tobias
- Lieb, Roselind
- Linde, Mattias
- Ljungcrantz, Christina
- Melin, Beatrice
- Moscarelli, Massimo
- Preisig, Martin
- Pugliatti, Maura
- Steinhausen, Hans-Christoph
- Stovner, Lars Jacob
- Vallat, Jean-Michel
- Xu, Weili
- Olesen, Jes
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 21
- Issue
- 10
- Pages
- 718-779
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2131786905
- Cited by
- 1,723
- References
- 427
- Citations by year
- 2026: 42 · 2025: 64 · 2024: 70 · 2023: 88 · 2022: 100 · 2021: 133 · 2020: 123 · 2019: 120 · 2018: 233 · 2017: 130 · 2016: 141 · 2015: 142 · 2014: 124 · 2013: 118 · 2012: 81
- FWCI
- 145.35
- Type
- journal article
- Language
- en
- Open access
- green
- tud.qucosa.de
- Licence
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- IRIS (submittedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- mental illness, neurological disorders, economic burden, prevalence, direct and indirect costs, cost model, Europe, brain tumors, dementia, epilepsy, multiple sclerosis, stroke, traumatic brain injury, Parkinson's disease, migraine, developmental disorders, neuromuscular disorders, sleep disorders, somatoform disorders, cost per person
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Mental Disorders, Brain Diseases, Child, Child, Preschool, Europe, Health Expenditures, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Public Health, Prevalence, Health Care Costs, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
